National Academy of Inventors names Phillip d. Zamore, Ph.D., 2014 fellow

December 16, 2014

WORCESTER, MA - Phillip D. Zamore, PhD, a pioneer in the study of RNA silencing, also called RNA interference, was named a 2014 Fellow by the National Academy of Inventors (NAI). The NAI awarded the distinction of Fellow to 170 esteemed innovators and inventors today. This brings the total number of fellows, representing more than 150 prestigious research universities and governmental and non-profit research institutions, to 414.

Election to NAI Fellow status is a high professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. The academic inventors and innovators elected to the rank of NAI Fellow are named inventors on U.S. patents and were nominated by their peers.

Dr. Zamore, the Gretchen Stone Cook Chair in the Biomedical Sciences and professor of biochemistry & molecular pharmacology at the University of Massachusetts Medical School; a Howard Hughes Medical Institute Investigator; and co-director of the RNA Therapeutics Institute, is credited with identifying the biochemical machinery responsible for RNA silencing, the mechanism through which small pieces of genetic material can turn specific genes on or off. Among his many discoveries, he showed how short segments of RNA act as guides during the silencing process, ensuring that the targeted gene is silenced.

Recognizing the power of RNAi as a research tool, scientists quickly began applying this knowledge in the lab; silencing genes one-by-one to determine the function of the proteins they produced. Now, researchers around the world are investigating the therapeutic power of RNAi, testing its ability to block the action of genes that have gone awry in diseases. Working with his UMMS colleagues, Zamore is using RNAi technologies to help design a therapy for Huntington's disease, a devastating neurodegenerative disease caused by one defective gene on a single chromosome. The hope is that small interfering RNAs can be used to selectively turn off the defective gene without harming the healthy gene on the other chromosome, which is needed for survival. He began the work after UMMS Professor of Medicine and Cell Biology Neil Aronin, MD, asked for his help in developing a treatment that shuts down the Huntington's gene.

Zamore continues his work combining biochemistry with genetics and cell biology to understand the biological functions and the molecular basis of the RNAi pathway; specifically his team has found that small RNAs-- a class that includes small interfering RNAs, microRNAs, and Piwi-interacting RNAs --contain many layers of information that guide the gene-silencing process. The RNA sequence on the molecule specifies not only which gene will be silenced but also how that silencing will occur.

A member of the UMMS community since 1999, Zamore received his AB (1986) and his PhD (1992) from the Department of Biochemistry and Molecular Biology at Harvard University and was awarded a Life Sciences Research Foundation Fellowship to complete his post-doctoral study at the Whitehead Institute at the Massachusetts Institute of Technology. Since joining UMMS, he was named a 2000 Pew Scholar in Biomedical Sciences by the Pew Charitable Trusts and, in 2002, was appointed a grant recipient under the W. M. Keck Foundation's Distinguished Young Scholars in Medical Research Program. In 2008, he was named a Howard Hughes Medical Institute Investigator, one of the most prestigious and sought-after scientific designations in the world. In 2009, he was the recipient of the Schering-Plough Award from the American Society for Biochemistry and Molecular Biology.

Prior NAI fellows from UMass Medical School include: Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, Blais University Chair in Molecular Medicine and distinguished professor of molecular medicine and cell and developmental biology; Robert H. Brown Jr., DPhil, MD, the Leo P. and Theresa M. LaChance Chair in Medical Research and chair and professor of neurology; John E. Ware, PhD, professor of quantitative health sciences; and Roger J. Davis, PhD, Howard Hughes Medical Institute Investigator, H. Arthur Smith Chair in Cancer Research and professor of molecular medicine and biochemistry & molecular pharmacology.

The NAI Fellows will be inducted by the Deputy U.S. Commissioner for Patent Operations, from the United States Patent and Trademark Office (USPTO), during the 4th Annual Conference of the National Academy of Inventors, on March 20, 2015, at the California Institute of Technology in Pasadena.

Fellows will be presented with a special trophy, newly designed medal, and a rosette pin in honor of their outstanding accomplishments. To honor these academic luminaries of invention and innovation, a plaque listing the name and institution of each NAI Fellow will be on permanent display at the USPTO. The 2014 NAI Fellows will be recognized with a full page announcement in The Chronicle of Higher Education Jan. 16, 2015 issue, and in upcoming issues of Inventors Digest and Technology and Innovation.

Included among all of the NAI Fellows are 61 presidents and senior leadership of research universities and non-profit research institutes, 208 members of the other National Academies (NAS, NAE, IOM), 21 inductees of the National Inventors Hall of Fame, 16 recipients of the U.S. National Medal of Technology and Innovation, 10 recipients of the U.S. National Medal of Science, 21 Nobel Laureates, 11 Lemelson-MIT prize recipients, 107 AAAS Fellows, and 62 IEEE Fellows, among other awards and distinctions.

The 2014 NAI Fellows Selection Committee comprises 17 members, including NAI Fellows, recipients of U.S. National Medals, National Inventors Hall of Fame inductees, members of the National Academies and senior officials from the USPTO, Association of American Universities, American Association for the Advancement of Science, Association of University Technology Managers, and National Inventors Hall of Fame.
About the University of Massachusetts Medical School

The University of Massachusetts Medical School (UMMS), one of five campuses of the University system, comprises the School of Medicine, the Graduate School of Biomedical Sciences, the Graduate School of Nursing, a thriving research enterprise and an innovative public service initiative, Commonwealth Medicine. Its mission is to advance the health of the people of the commonwealth through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education. The Medical School attracts more than $240 million annually in research funding, placing it among the top 50 medical schools in the nation. In 2006, UMMS's Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator and the Blais University Chair in Molecular Medicine, was awarded the Nobel Prize in Physiology or Medicine, along with colleague Andrew Z. Fire, PhD, of Stanford University, for their discoveries related to RNA interference (RNAi). The 2013 opening of the Albert Sherman Center ushered in a new era of biomedical research and education on campus. Designed to maximize collaboration across fields, the Sherman Center is home to scientists pursuing novel research in emerging scientific fields with the goal of translating new discoveries into innovative therapies for human diseases.

About The National Academy of Inventors

The National Academy of Inventors® is a 501(c)(3) non-profit member organization comprised of U.S. and international universities, and governmental and non-profit research institutions, with over 3,000 individual inventor members and Fellows spanning more than 200 institutions, and growing rapidly. It was founded in 2010 to recognize and encourage inventors with patents issued from the U.S. Patent and Trademark Office, enhance the visibility of academic technology and innovation, encourage the disclosure of intellectual property, educate and mentor innovative students, and translate the inventions of its members to benefit society. The NAI edits the multidisciplinary journal, Technology and Innovation, published by Cognizant Communication Corporation (NY).

University of Massachusetts Medical School

Related Cell Biology Articles from Brightsurf:

Deep learning on cell signaling networks establishes AI for single-cell biology
Researchers at CeMM have developed knowledge-primed neural networks (KPNNs), a new method that combines the power of deep learning with the interpretability of biological network models.

RNA biology provides the key to cell identity and health
Two papers in Genome Research by the FANTOM Consortium have provided new insights into the core regulatory networks governing cell types in different vertebrate species, and the role of RNA as regulators of cell function and identity.

Cell biology: Your number's up!
mRNAs program the synthesis of proteins in cells, and their functional lifetimes are dynamically regulated.

Cell biology -- maintaining mitochondrial resilience
Mitochondria cannot autonomously cope with stress and must instead call on the cell for help.

Cell biology: All in a flash!
Scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich have developed a tool to eliminate essential proteins from cells with a flash of light.

A biology boost
Assistance during the first years of a biology major leads to higher retention of first-generation students.

Cell-free synthetic biology comes of age
In a review paper published in Nature Reviews Genetics, Professor Michael Jewett explores how cell-free gene expression stands to help the field of synthetic biology dramatically impact society, from the environment to medicine to education.

Scientists develop electrochemical platform for cell-free synthetic biology
Scientists at the University of Toronto (U of T) and Arizona State University (ASU) have developed the first direct gene circuit to electrode interface by combining cell-free synthetic biology with state-of-the-art nanostructured electrodes.

In a first for cell biology, scientists observe ribosome assembly in real time
A team of scientists from Scripps Research and Stanford University has recorded in real time a key step in the assembly of ribosomes -- the complex and evolutionarily ancient 'molecular machines' that make proteins in cells and are essential for all life forms.

Cell biology: Endocannabinoid system may be involved in human testis physiology
The endocannabinoid system (ECS) may be directly involved in the regulation of the physiology of the human testis, including the development of sperm cells, according to a study in tissue samples from 15 patients published in Scientific Reports.

Read More: Cell Biology News and Cell Biology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to